Regular Insulin Dosing for Severe Hyperglycemia (500 mg/dL)
For a patient with a blood glucose of 500 mg/dL, administer intravenous regular insulin at an initial bolus dose of 0.15 units/kg followed by a continuous infusion at 0.1 units/kg/hour (typically 5-7 units/hour for adults). 1
Approach to Severe Hyperglycemia Management
Initial Assessment
- Determine if the patient has diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS)
- Check for hypokalemia (K+ < 3.3 mEq/L) before starting insulin therapy
- Assess hydration status and initiate appropriate fluid replacement
Insulin Administration Protocol
For Intravenous Administration (Preferred Method):
- Initial bolus: 0.15 units/kg of regular insulin IV
- Continuous infusion: 0.1 units/kg/hour (typically 5-7 units/hour for adults)
- Monitoring and adjustment:
- If glucose does not decrease by at least 50 mg/dL in the first hour, check hydration status
- If hydration is adequate, double the insulin infusion rate hourly until achieving a steady glucose decline of 50-75 mg/dL per hour 1
For Subcutaneous Administration (If IV Access Unavailable):
- For mild DKA only: Give "priming" dose of regular insulin at 0.4-0.6 units/kg, with half as IV bolus and half as subcutaneous injection
- Follow with 0.1 unit/kg subcutaneously every hour 1
Special Considerations
Transition to Subcutaneous Insulin
Once blood glucose reaches 250-300 mg/dL:
- Start basal-bolus insulin regimen
- Continue IV insulin for 1-2 hours after first subcutaneous dose to ensure adequate plasma insulin levels
- Avoid abrupt discontinuation of IV insulin 1
Sliding Scale for Subcutaneous Regular Insulin
For patients unable to receive IV insulin with glucose of 500 mg/dL:
- Use 20 units of regular insulin subcutaneously (based on sliding scale of 5 units for every 50 mg/dL above 150 mg/dL) 1
- Monitor glucose every 4-6 hours
Monitoring Parameters
- Check blood glucose every 1-2 hours until stable, then every 2-4 hours
- Monitor electrolytes, especially potassium
- For DKA, monitor resolution of ketosis (preferably using β-hydroxybutyrate measurements)
Pitfalls to Avoid
- Delayed treatment: Severe hyperglycemia requires prompt intervention to prevent complications
- Inadequate monitoring: Frequent glucose checks are essential to avoid hypoglycemia
- Premature discontinuation of IV insulin: Continue IV insulin for 1-2 hours after initiating subcutaneous insulin to prevent rebound hyperglycemia
- Neglecting fluid status: Adequate hydration is critical for insulin effectiveness and patient safety
- Relying on urine ketones: Blood β-hydroxybutyrate measurement is preferred for monitoring ketosis resolution 1
Remember that patients with severe hyperglycemia often have significant fluid deficits requiring aggressive rehydration alongside insulin therapy. The goal is to achieve a steady glucose decline while avoiding too rapid correction, which can lead to complications.